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A B S T R A C T
Artificially synthesized probiotic from Lactobacillus strain, contained in the tested toothpaste, led to an innovative ap-
proach in preventive dentistry. A new concept resulting from this research can be explained due to possible mechanisms
of action of probiotic bacteria, according to which equilibrium of hostile bacterial flora is achieved by mechanical elimi-
nation of cariogenic bacteria from the mouth. This research was conducted during a 4-week period on a randomly se-
lected Croatian sample of 50 participants, with the aim to investigate the efficacy of the first probiotic toothpaste ever pro-
duced in Croatia. CRT tests (Ivoclar Vivadent AG, FL-9494 Schaan / Liechtenstein) were used and individually admi-
nistrated to each participant to assess the number of Streptococci and Lactobacilli. Saliva samples were tested before, as
well as 2 and 4 weeks after using the tested toothpaste. After having had obtained detailed information on the research
protocol, participants signed informed consent, and strictly following the instructions, brushed their teeth exclusively us-
ing the tested toothpaste and toothbrush of the same manufacturer over the 4 week period. Statistical results obtained af-
ter 4 weeks of using the probiotic toothpaste showed significant reduction in the number of participants who, prior to
commencing the study, were diagnosed a high number of cariogenic bacteria. The number of participants with the high
number of streptococci was significantly reduced from 78.4 to 26.5%, as well as the number of participants with the high
number of Lactobacilli, which significantly dropped down from 52.9 to 26.5%. The results indicate a significant efficacy
of the tested toothpaste, which can be attributed to the effect of the contained synthetized probiotic substance. Therefore,
this research reveals a new achievement in innovative technologies, based on which probiotics can be used with purpose
of maintaining balance of bacterial flora within the oral cavity, particularly in high risk groups who are more prone to
developing caries.
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Introduction
The recent achievements in oral microbiology have
proven a diverse range of more than 700 bacterial species
which are incorporated in the dental biofilm (plaque) in
the form of colonised pellicle coat1,3. In the presence of
fermentable carbochydrates, these bacteria produce ac-
ids that commence a localised demineralization of the
tooth hard tissue, finally resulting in dental caries which
is known as the most common and major oral disease
caused by the oral microbial flora4,5. With respect to the
latest concept of dental diseases caused due to oral mi-
crobial interactions, an important shift has suggested a
new approach for controlling dental caries via modulat-
ing the oral microbial ecology. This approach suggests
the selective inhibition of oral pathogens or modulation
of the microbial composition of dental plaque in order to
control microbial pathogenesis. It could be achieved by
applying mechanical means and improved by introducing
toothpastes and mouthrinses which involve probiotics as
tremendously effective in preventing oral diseases and
maintaining oral health. Following this updated concept,
inovative technology in dentistry has presented a newly
synthesized product made from a probiotic microorgan-
ism strain Lactobacillus paracasei, known as pro-t-ac-
tion, which represents a therapeutic innovation that can
serve in the battle against caries. The active ingredient
in pro-t-action was proved to bind to and eliminate caus-
ing bacteria caries from the mouth. associated salivary
microbial counts, i.e. Streptococcus mutans and Lactoba-
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cillus, which are normally present in the mouth. The ob-
jective was also to evaluate a potential influence of the
same toothpaste on the saliva buffer capacity. Following
this updated concept, inovative technology in dentistry
has presented a newly synthesized product made from a
probiotic microorganism strain Lactobacillus paracasei,
known as pro-t-action, which represents a therapeutic
innovation that can serve in the battle against caries.
The active ingredient in pro-t-action was proved to bind
to and eliminate causing bacteria caries from the mouth.
associated salivary microbial counts, i.e. Streptococcus
mutans and Lactobacillus, which are normally present in
the mouth. The objective was also to evaluate a potential
influence of the same toothpaste on the saliva buffer ca-
pacity associated salivary microbial counts, i.e. Strepto-
coccus mutans and Lactobacillus, which are normally
present in Following this updated concept, inovative
technology in dentistry has presented a newly synthe-
sized product made from a probiotic microorganism strain
Lactobacillus paracasei, known as pro-t-action, which
represents a therapeutic innovation that can serve in the
battle against caries. The active ingredient in pro-t-ac-
tion was proved to bind to and eliminate causing bacteria
caries from the mouth. associated salivary microbial counts,
i.e. Streptococcus mutans and Lactobacillus, which are
normally present in the mouth. The objective was also to
evaluate a potential influence of the same toothpaste on
the saliva buffer capacity.
Materials and Methods
A randomly selected sample of 50 volunteers who
were 4- and 5-year attendants of the School of Dental
Medicine of the University of Zagreb, aged between 20
and 24 years, were included in this 4-week clinical trial.
All subjects were equally divided by genders. The num-
ber of bacteria present in the mouth was evaluated by us-
ing a specific method, i.e. the standardt CRT evaluation,
which has proved to be an objective method for detection
of bacterial counts. At the screening, all participants rep-
resented within the normal range and showed no signs of
abnormality or extremely high or low bacterial counts.
Therefore, a placebo group was not introduced in this
study. Prior to commencing the study, all participants
were explained the purpose of the study as well as all the
requirements established by the protocol criteria and the
product itself. After giving consent, they agreed on vol-
unteering in the study. The toothpaste had previously
been clinically tested in The Pliva Research Institute in
Zagreb and the Dental Clinic at the Johannes Gutenberg
University in Mainz and approved of by the Croatian De-
partment of Health. It had been produced according to
ISO 9001/14001 integrated quality normatives, which
the company (Neva, Croatia) first introduced in Croatia.
The raw materials were obtained from western Euro-
pean suppliers and were all EU quality certificated and
met health regulations. The products had proved free of
harmful abrasive materials and hadn’t been tested on
animals. All participants were supplied by probiotic tooth-
pastes (Pro-T-Action, Plidenta, Neva, Croatia), which
contained an active substance i.e. pro-t-action, and by
medium hard toothbrushes as well (Plidenta, Neva, Cro-
atia). They were instructed to brush their teeth thor-
oughly 2 times a day and were asked to use dental floss.
In the period of duration of the study, subjects were re-
strained from using any other toothpaste or oral product
from another supplier. They were strongly suggested to
remain within the usual dietary protocol. Any partici-
pant who might have represented with an allergic reac-
tion that potentially could be related to the labeled tooth-
paste, was supposed to be excluded from the study
immediately. In medical history, exclusion criteria re-
ferred to any major chronic or systemic diseases that
might have interfered with the content of the labeled
product. Subjects with the history of smoking, immune
system incompetency, and gastrointestinal disturbances
were excluded as well. Dental history exclusion criteria
involved gross caries lesions, extensive prosthetic work,
tooth abnormalities (such as dentinogenesis or amelo-
genesis), odontodysplasia and periodontal diseases. Only
one participant was excluded in parts of duration of the
study due to combining the labeled toothpaste with an-
other oral hygiene product. By applying a standard CRT
(Ivoclar Vivadent AG, FL-9494 Schaan/Liechtenstein)
test evaluation, screening of the participants was accom-
plished by detecting the number of cariogenic bacteria
(Streptococci and Lactobacilli) at the initial visit. Based
on the bacterial count at the initial visit, all participants
were grouped either in a: A/ group with a low Streptococ-
cus mutans and Lactobacillus count (<105), or B/ group
with a high Streptococcus mutans and Lactobacillus
count (³105). Prior to applying CRT tests, individual
samples of stimulated saliva were used to obtain buffer
capacity for each subject. The rest of the stimulated sa-
liva samples were further individually tested by using
CRT tests. Upon collecting stimulated saliva from an in-
dividual subject, each CRT sample was kept in the ter-
mostat at 37 °C over the 48 hour period, after which time
the number of Streptococci and Lactobacilli were coun-
ted. CRT tests were individually applied to each subject
at the 1st, 2nd and 4th week check-ups, during which
time the subjects were instructed to brush their teeth fol-
lowing the required protocol. Buffer capacity (i.e. pH
value) was measured at the 2nd and 4th week check-up
intervals.
Statistics
Statistical analysis was performed by using IBM
SPSS Statistics 20 for Windows. For the purpose of the
study, the results were performed in the form of tables
and graphs. Chi-square test was performed difference
with respect to age. Non-parametric Cochran’s Q test
was performed to represent the changes in the bacterial
counts in both tested groups (Streptococcus and Lacto-
bacillus). Wilcoxon Signed Rank test was performed to
test buffer capacity.
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Results
As to gender, no statisticallly significant difference
was found neither with respect to the number of Srepto-
cocci and Lactobacilli, or the pH value. With respect to
the number of cariogenic bacteria (Streptococci and Lac-
tobacilli) counted at the 1st visit, before the participants
started to use Plidenta Pro-T-action toothpaste, the re-
sults obtained after 4 weeks showed a significant reduc-
tion in both Streptococcus mutans and Lactobacillus bac-
teria counts as rated by CRT tests. The results repre-
senting the group with high Streptococcus mutans count
(³105) have shown a significant decrease by dropping
down from high 78.4% at the 1st visit to significantly
lower 26.5% after 4 weeks of using the probiotic tooth-
paste (Table 1, Figure 1). A decrease in the number of
participants with the high Lactobacillus count (³105) was
observed as well, significantly dropping down from high
52.9% at the 1st visit to a low 26.5% after a 4 week
check-up interval (Table 2, Figure 2). On the contrary, no
significant changes were observed with respect to the pH
value between a 2nd and 4th week check-up intervals as
represented by Wilcoxon Signed Rank test (Table 3) and
Figure 3.
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TABLE 1
COCHRAN’S Q TEST FOR STREPTOCOCCUS MUTANS BEFORE, 2 AND 4 WEEKS AFTER USING TOOTHPASTE




Initial visit (prior to using toothpaste) 10 39 N=49
2 weeks after using toothpaste 23 26 df=2
4 weeks after using toothpaste 36 13 p<0.001
TABLE 2
COCHRAN’S Q TEST FOR LACTOBACILLUS COUNT BEFORE, 2 AND 4 WEEKS AFTER USING TOOTHPASTE




Initial visit (prior to using toothpaste) 23 26 N=49
2 weeks after using toothpaste 32 17 df=2
4 weeks after using toothpaste 36 13 p<0.001
N=total number of participants; df=derees of freedom
Fig. 2. Lactobacillus counts at 1st (prior to using Pro-T-Action
toohpaste), 2nd and 4th check-up.
Fig. 1. Streptococcus mutans counts at 1st (prior to using pro-
-t-action tothpaste), 2nd and 4th check-up.
Discussion and Conclusion
Probiotics include mostly bacteria, but moulds and
yeasts as well, and were defined in 2001 as »live microor-
ganisms which confer a health benefit on the host when
administered in adequate amounts«6,7. Research studies
have so far revealed diverse beneficial effects of probio-
tics, which potentially range from direct inhibition of
pathogenic microbes to improving host immune func-
tions8. In this context, lactic acid bacteria have been de-
tected as species which was the most widely used in
probiotic preparations. The utmost interest have lately
been focused on applying probiotic therapy with the aim
of maintenaning oral health, i.e. preventing or treating
oral health diseases and development of caries, as well as
resolving periodontal issues9-11. Some of the probiotic
strains, such as those belonging to the genera Lacto-
bacillus and Bifidobacterium, have been tested world-
wide for their ability to confer probiotic effects on the
oral flora. As to dental caries, it is not merely the pres-
ence of a single organism, such as Streptococcus mutans
bacteria, but the interactions between the biofilm resi-
dents that appears crucial and determines the properties
of a biofilm12,13. Acid-producing Streptococcus mutans
and Lactibacillus bacteria are believed to play a major
role in initiation and development of dental caries14. Af-
ter exposed to sacharosis, Streptococcus mutans under-
goes the process of autoaggregation which results in in-
creasing its number that is further present in saliva.
Consequently, these multiplied bacteria adhere to the
tooth enamel and being permanently present in the form
of oral biofilm are responsible for tooth decay15. It has
been suggested that some probiotic cultures of Lacto-
bacillus species can be effective in forming co-aggrega-
tions with Streptococcus mutans bacteria, which results
in further elimination of Streptococcus mutans from the
oral cavity. This specific coaggregation does not depend
on temperature and has proved to be stabile in the pres-
ence of protease and other proteolytic enzymes or pro-
teins16. However, co-aggregation is dependant on calcuim
and cannot be completed in the presence of ethylene-
diaminetetraacetic acid (EDTA), whereas the presence of
saliva ranging from 4.0 to 8.0 pH values does not signifi-
cantly influence it17. Furthermore, Lactobacillus doesn’t
seem to show affinity to binding to hydroxil-apatite crys-
tals or other type of benign oral flora which colonizes
tongue, i.e. Streptococcus salivarius, which further leads
to a conclusion that no oportunistic infections might be
expected in the presence of Lactobacillus species17. This
innovative approach based on microbiological investiga-
tions suggests that some Lactobacillus species may ex-
hert probiotic effect via different vecchiculum, such as
toothpastes or mouthrinses. Our results are in accor-
dance with the proposed presumptions and therefore
suggest that the effect of this innovative probiotic tooth-
paste (Plidenta Pro-T-Action, Neva, Croatia) is due to
Lactobacillus paracasei contained in the synthetised pro-
-t-action substance, that has the unique ability to very
precisely target the caries causing bacteria and binding
exclusively to them further results in clumping them.
When aggregated and grouped together, the bacteria can
be flushed out of the oral cavity by normal swallowing or
rinsing. An advantage of Lactobacillus paracasei is that
it needs to remain in the oral cavity for only a minimum
of ten seconds to become active23. Some clinial studies
have reported up to even 50% decrease in the Streptococ-
cus mutans bacteria count after using Lactobacillus pa-
racasei mouthrinse18. A reduction of the amount of
Streptococcus mutans bacteria in the mouth was re-
ported after using Lactobacillus paracasei candies as
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TABLE 3
WILCOXON SIGNED RANKS TEST FOR BUFFER CAPACITY (PH VALUE) AFTER USING TOOTHPASTE
pH value after using toothpaste N X Rank Sum of Ranks
Wilcoxon Signed
Ranks Test
4 weeks post-treatment <2 weeks post-treatment 9 9.00 81.00
Z=–0.243
p=0.808
4 weeks post-treatment >2 weeks post-treatment 8 9.00 72.00
4 weeks post-treatment =2 weeks post-treatment 32
Total 49
N=total number of participants
Fig. 3. Buffer capacity (pH values) in participants before, 2 and 4
weeks after using toothpaste.
well19. In the light of these recent achievements in sci-
ence, a new launched toothpaste containing probiotic
strain Lactobacillus paracasei (Plidenta, Neva, Croatia)
represents an innovative product with improved anti-
cariogenic properties and has so far shown excellent re-
sults in reducing the amount of Streptococcus mutans
bacteria. The results of this study proved that a daily us-
age of this probiotic toothpaste interferes with the num-
ber of plaque-accumulated Streptococcus mutans and
Lactobacillus bacteria, that have proven cariogenic ef-
fects and are regularly present in saliva19. The results
also showed an immediate effect of Lactobacillus para-
casei on Streptococcus mutans and Lactobacillus counts
which was reported during the 2nd and 4th week inter-
vals of using exclusively the selected toothpaste contain-
ing pro-t-action substance. The reported results are in
accordance with some microbiological reports which sug-
gested that a certain 2 week-period may be needed for
Lactobacillus paracasei to become effective in probiotic
action20. As oposed to our study, a certain tendency for an
increase in Lactobacillus counts after consuming some
probiotic products contained in foods was suggested ac-
cording to some clinical study reports20–22. However, so-
me studies on cheese and yoghurt consumption sug-
gested a posttreatment effect which was present for up to
2 weeks after discontinuing the consumption of the prod-
ucts containing probiotic strains of Lactobacillus spe-
cies20,23. It could imply that different Lactobacillus spe-
cies exhisting in the oral cavity and gastrointestinal tract
may exhert different probiotic effects. Although probio-
tics have shown scientifically proven benefits, further
studies are mandatory in order to investigate their mech-
anism of posttreatment action as well. Based on the pro-
posed achievements, researches have been able to use the
proposed mechanism of probiotic action giving the em-
phasis on the metabolism of »good bacteria« that are nor-
mally present in saliva. A newly produced toothpaste
which contains a laboratory synthetised pro-t-action sub-
stance with an active Lactobacillus paracasei probiotic
strain showed ability to balance Streptococcus mutans
bacteria and represents a new concept in the oral hy-
giene measurements. It could be recommended as a ther-
apeutic toothpaste particularly in patients who are at
high risk for caries.
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NOVA DOSTIGNU]A U PREVENTIVNOJ STOMATOLOGIJI TEMELJENA NA ISPITIVANJU
NOVE PROBIOTI^KE PASTE ZA ZUBE
S A @ E T A K
Umjetno sintetizirani probiotik iz soja laktobacila koji je sadr`an u testiranoj zubnoj pasti omogu}io je inovativni
pristup u preventivnoj stomatologiji. Primjenjen je novi koncept djelovanja mehanizma probioti~kih bakterija, prema
kojemu se ekvilibrij bakterijske flore normalno prisutne u usnoj {upljini posti`e temeljem mehani~ke eliminacije karije-
sogenih bakterija iz usne {upljine. Ovo klini~ko ispitivanje provedeno je u periodu od 4 tjedna na uzorku od 50 ispita-
nika hrvatske populacije. Cilj istra`ivanja bio je ispitati u~inkovitost zubne paste koja sadr`i probioti~ki soj bakterija, te
je kao takva prvi puta proizvedena u Hrvatskoj. U istra`ivanju su kori{teni CRT testovi (Ivoclar Vivadent AG, FL-9494
Schaan/Liechtenstein) temeljem kojih se individualno u svakog ispitanika procijenio broj karijesogenih bakterija
(Streptococcus mutansa i Lactobacilla). Pojedina~ni uzorci sline testirani su prije po~etka kori{tenja zubne paste, te
nakon 2 i 4 tjedna. Ispitanici su nakon detaljnih informacija u vezi s klini~kim testiranjem, potpisali pristanak i, pridr-
`avaju}i se temeljitih uputstava proizvo|a~a, u narednih 4 tjedna odr`avali oralnu higijenu koriste}i isklju~ivo tesiranu
zubnu pastu i odgovaraju}u ~etkicu istog proizvo|a~a Statisti~ki rezultati nakon 4 tjedna kori{tenja probioti~ke zubne
paste pokazali su zna~ajno smanjenje broja ispitanika u kojih je na po~etku istra`ivanja dijagnosticiran visoki broj
karijesogenih bakterija. Broj ispitanika sa visokim brojem streptokoka zna~ajno se smanjio sa 78,4 na 26,5%, a broj
ispitanika sa visokim brojem laktobacila zna~ajno je pao sa 52,9 na 26,5%. Rezultati istra`ivanja ukazuju na zna~ajnu
u~inkovitost testirane zubne paste, a koja se potencijalno mo`e pripisati djelovanju sinteti~ki proizvedene probioti~ke
supstance koja je sadr`ana u testiranoj zubnoj pasti.. Stoga ovo klini~ko istra`ivanje otvara nove mogu}nosti glede
inovativnih tehnologija temeljem kojih se probiotici koriste u svrhu odr`avanja ravnote`e bakterijske flore, poglavito u
skupinama visokog rizika i sklonosti spram karijesa.
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